{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:03:53Z","timestamp":1789124633257,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T00:00:00Z","timestamp":1556582400000},"content-version":"vor","delay-in-days":119,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007214","name":"Velux Stiftung","doi-asserted-by":"publisher","award":["1123"],"award-info":[{"award-number":["1123"]}],"id":[{"id":"10.13039\/100007214","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018841","name":"Associazione Italiana Ricerca Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018841","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["SNF 320030_169876"],"award-info":[{"award-number":["SNF 320030_169876"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.nicl.2019.101846","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T21:01:16Z","timestamp":1556917276000},"page":"101846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4094-9942","authenticated-orcid":false,"given":"A.","family":"Chincarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Peira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Morbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bauckneht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Arbizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Castelo-Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"B\u00fcsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"de Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Didic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dottorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Engelborghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.","family":"Frisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Garibotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hausner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hugon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mecocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Musarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Queneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Riverol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.P.","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nicl.2019.101846_bb0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.nicl.2019.101846_bb0010","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.neuroimage.2010.09.025","article-title":"Reproducible evaluation of ANTs similarity metric performance in brain image registration","volume":"54","author":"Avants","year":"2011","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.nicl.2019.101846_bb0015","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3233\/JAD-160232","article-title":"Standardized uptake value ratio-independent evaluation of brain amyloidosis","volume":"54","author":"Chincarini","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2019.101846_bb0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neurobiolaging.2016.07.012","article-title":"Geneva Task Force for the Roadmap of Alzheimer's Biomarkers. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework","volume":"52","author":"Chiotis","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"13","key":"10.1016\/j.nicl.2019.101846_bb0025","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1007\/s00259-018-4081-5","article-title":"Amyloid involvement in subcortical regions predicts cognitive decline","volume":"45","author":"Cho","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.nicl.2019.101846_bb0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2967\/jnumed.118.211532","article-title":"Assessing amyloid pathology in cognitively normal subjects using [18F] flutemetamol PET: comparing visual reads and quantitative methods","volume":"60","author":"Collij","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2019.101846_bb0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jamaneurol.2014.4144","article-title":"Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density","volume":"72","author":"Curtis","year":"2015","journal-title":"JAMA Neurol"},{"issue":"17","key":"10.1016\/j.nicl.2019.101846_bb0040","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.0b013e3181a2e8d0","article-title":"Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease","volume":"72","author":"Drzezga","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nicl.2019.101846_bb0045","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.nicl.2019.101846_bb0050","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jamaneurol.2017.0892","article-title":"Association of longitudinal cognitive decline with amyloid burden in middle-aged and older adults evidence for a dose-response relationship","volume":"74","author":"Farrell","year":"2017","journal-title":"Jama Neurol."},{"issue":"11","key":"10.1016\/j.nicl.2019.101846_bb0055","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","article-title":"Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease","volume":"68","author":"Fleisher","year":"2011","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.nicl.2019.101846_bb0060","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","article-title":"Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers","volume":"16","author":"Frisoni","year":"2017","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.nicl.2019.101846_bb0065","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.nicl.2019.101846_bb0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.nicl.2014.01.016","article-title":"LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo","volume":"4","author":"Grimmer","year":"2014","journal-title":"Neuroimage Clin"},{"issue":"20","key":"10.1016\/j.nicl.2019.101846_bb0075","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","article-title":"Alzheimer's disease neuroimaging initiative. In vivo staging of regional amyloid deposition","volume":"89","author":"Grothe","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nicl.2019.101846_bb0080","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer's disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.nicl.2019.101846_bb0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2019.101846_bb0090","series-title":"Positron Emission Tomography-Computed Tomography Standardized Uptake Values in Clinical Practice and Assessing Response to Therapy","author":"Kinahan","year":"2010"},{"issue":"1","key":"10.1016\/j.nicl.2019.101846_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"12","key":"10.1016\/j.nicl.2019.101846_bb0100","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nicl.2019.101846_bb0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"8","key":"10.1016\/j.nicl.2019.101846_bb0110","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","article-title":"SNMMI procedure standard\/EANM practice guideline for amyloid PET imaging of the brain 1.0","volume":"57","author":"Minoshima","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.nicl.2019.101846_bb0115","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jalz.2014.03.003","article-title":"The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative","volume":"10","author":"Molinuevo","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.nicl.2019.101846_bb0120","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3174\/ajnr.A4281","article-title":"Alzheimer's disease neuroimaging initiative. Use of standardized uptake value ratios decreases interreader variability of [18F] florbetapir PET brain scan interpretation","volume":"36","author":"Nayate","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.nicl.2019.101846_bb0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-170327","article-title":"The cerebrospinal fluid A\u03b21\u201342\/A\u03b21\u201340 ratio improves concordance with amyloid-PET for diagnosing Alzheimer's disease in a clinical setting","volume":"60","author":"Niemantsverdriet","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2019.101846_bb0130","article-title":"Comparison of visual criteria for amyloid Positron Emission Tomography reading: could their merging reduce the inter-raters variability","author":"Paghera","year":"2019","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.nicl.2019.101846_bb0135","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/brain\/aww015","article-title":"Cerebrospinal fluid analysis detects cerebral amyloid-b accumulation earlier than positron emission tomography","volume":"139","author":"Palmqvist","year":"2016","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.nicl.2019.101846_bb0140","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00259-015-3067-9","article-title":"Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings","volume":"42","author":"Payoux","year":"2015","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"Pt 9","key":"10.1016\/j.nicl.2019.101846_bb0145","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.nicl.2019.101846_bb0150","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \"probable\" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.nicl.2019.101846_bb9000","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jalz.2014.09.004","article-title":"The Influence of Biological and Technical Factors on Quantitative Analysis of Amyloid PET: Points to Consider and Recommendations for Controlling Variability in Longitudinal Data","volume":"11","author":"Schmidt","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"Suppl. 1","key":"10.1016\/j.nicl.2019.101846_bb0155","first-page":"S349","article-title":"Long night's journey into the day: amyloid-\u03b2 imaging in Alzheimer's disease","volume":"33","author":"Villemagne","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"11","key":"10.1016\/j.nicl.2019.101846_bb0160","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrneurol.2017.147","article-title":"A systemic view of Alzheimer disease \u2013 insights from amyloid-\u03b2 metabolism beyond the brain","volume":"13","author":"Wang","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nicl.2019.101846_bb0165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1119\/1.1632486","article-title":"Unified equations for the slope, intercept, and standard errors of the best straight line","volume":"72","author":"York","year":"2004","journal-title":"Am. J. Phys."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158219301962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158219301962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:41:53Z","timestamp":1778852513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158219301962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":34,"alternative-id":["S2213158219301962"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2019.101846","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2019.101846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101846"}}